stockrowAlamar Biosciences, Inc. (ALMR) vs TransMedics Group, Inc. (TMDX)
- Alamar Biosciences, Inc. ALMR 27.48 +2.12%
- TransMedics Group, Inc. TMDX 87.04 +26.18%
Alamar Biosciences, Inc. and TransMedics Group, Inc. are both Medical Devices companies. TransMedics Group, Inc. is the larger, with a market value of $2.4B against $1.9B — 1.3× the size. Alamar Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; TransMedics Group, Inc. trades at 16.4×. TransMedics Group, Inc. has the higher net margin (19.9% vs −52.2%) and the higher return on invested capital (48.0% vs −10.1%). Across the 16 metrics below, TransMedics Group, Inc. leads on 14 and Alamar Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | ALMR | TMDX | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.38% | 58.60% | 57.76% |
| Operating margin | (46.53%) | 11.88% | (15.07%) |
| Net margin | (52.19%) | 19.85% | (14.45%) |
| Free cash flow margin | (104.68%) | 6.14% | (3.88%) |
| Return on equity | (64.46%) | 31.89% | (10.35%) |
| Return on assets | (20.81%) | 11.73% | (17.26%) |
| Return on invested capital | (10.07%) | 48.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack